Mayo Clinic completes implementation of new SCC Soft Computer laboratory information system

April 30, 2012

Mayo Clinic today announced that it has completed a multiyear implementation of a new laboratory information system for the Department of Laboratory Medicine and Pathology and Mayo Medical Laboratories. The new system, which connects Mayo laboratories in Arizona, Minnesota and New England, was developed in collaboration with SCC Soft Computer of Clearwater, Fla.

Mayo Medical Laboratories, Mayo Clinic's reference laboratory, now has the most advanced laboratory in the market. The single system allows Mayo to manage testing in multiple locations, provides real-time location of a specimen, and enables continuous improvement in turnaround times and processes. The new laboratory information system helps Mayo Medical Laboratories to offer its clients broader ordering and resulting configurations (e.g., partial results, flagging, and richer test result details). Additionally, the system has helped Mayo Medical Laboratories process client specimens more efficiently to further improve turnaround times.

"We are excited to take yet another forward step in the pathway of ," says Franklin R. Cockerill, M.D., chair of the Department of Laboratory Medicine and Pathology, and president and CEO of Mayo Medical Laboratories. "Mayo is delivering on its commitment to provide the highest-quality, patient-focused laboratory medicine and pathology in the world. Our hospital and medical center lab clients, as well as patients worldwide, will benefit directly from the successful replacement of our entire laboratory information system." The SCC Soft Computer laboratory information system now manages all inpatient and outpatient collections in Minnesota and Arizona as well as the majority of laboratory testing in Arizona, Minnesota and Mayo Medical Laboratories New England.

"SCC is proud to lead the modernization of the laboratory information systems at ," says Gilbert Hakim, chief executive officer of SCC Soft Computer. "By putting forth continuous effort to stay ahead of trends in the health care field, SCC focuses not only on the improvement of existing software suites, but the development of new and advanced products as well. This works perfectly with an innovative partner like Mayo."

Explore further: Mayo Clinic finds new bacterium causing tick-borne illness ehrlichiosis in Wisconsin and Minnesota

Related Stories

Mayo Clinic finds new bacterium causing tick-borne illness ehrlichiosis in Wisconsin and Minnesota

August 4, 2011
A new tick-borne bacterium infecting humans with ehrlichiosis has been discovered in Wisconsin and Minnesota. It was identified as a new strain of bacteria through DNA testing conducted at Mayo Clinic. The findings appear ...

Mayo Clinic finds surgeon caseload, practice setting affect treatment of small kidney tumors

May 15, 2011
Patients with small kidney tumors are more likely to be offered treatment options based on surgeons' case volume and type of practice than on tumor characteristics, a Mayo Clinic study has found. Fellowship-trained surgeons ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.